Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset patterns and genetic backgrounds. This study aims to examine the genetic landscape and clinical implications of rare mutations in Chinese breast cancer patients.Methods: Clinical data from 253 patients, including sporadic and familial cases, were analyzed. Comprehensive genomic profiling was performed, categorizing identified rare variants according to the American College of Medical Genetics (ACMG) guidelines. In silico protein modeling was used to analyze potentially pathogenic variants’ impact on protein structure and function.Results: We detected 421 rare variants across patients. The most frequently mutated genes were ALK (22.2%), BARD1 ...
Abstract Germline-somatic mutation interactions are universal and associated with tumorigenesis, but...
Introduction: Germline mutations of BRCA1 and BRCA2 account for the majority of hereditary breast ca...
Over the past 20 years, high-penetrance pathogenic mutations in genes BRCA1, BRCA2, TP53, PTEN, STK1...
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset ...
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset ...
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset ...
Introduction:FANCC is reported as a novel susceptibility gene for breast cancer, however, its mutati...
The widespread adoption of gene panel testing for cancer predisposition is leading to the identifica...
Abstract Genetic testing for germline mutations in BRCA1/2 of patients with breast cancer (BC) is p...
BRCA1 and BRCA2 as important DNA repair genes have been thoroughly investigated in abundant studies....
Purpose: The aim of this study is to further understand the status of BRCA1 and BRCA2 mutation among...
Over the past 20 years, high-penetrance pathogenic mutations in genes BRCA1, BRCA2, TP53, PTEN, STK1...
Purpose: The aim of this study is to further understand the status of BRCA1 and BRCA2 mutation among...
Importance: Rare germline genetic variants in several genes are associated with increased breast can...
Although evidence suggests an importance of genetic factors in the development of breast cancer in T...
Abstract Germline-somatic mutation interactions are universal and associated with tumorigenesis, but...
Introduction: Germline mutations of BRCA1 and BRCA2 account for the majority of hereditary breast ca...
Over the past 20 years, high-penetrance pathogenic mutations in genes BRCA1, BRCA2, TP53, PTEN, STK1...
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset ...
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset ...
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset ...
Introduction:FANCC is reported as a novel susceptibility gene for breast cancer, however, its mutati...
The widespread adoption of gene panel testing for cancer predisposition is leading to the identifica...
Abstract Genetic testing for germline mutations in BRCA1/2 of patients with breast cancer (BC) is p...
BRCA1 and BRCA2 as important DNA repair genes have been thoroughly investigated in abundant studies....
Purpose: The aim of this study is to further understand the status of BRCA1 and BRCA2 mutation among...
Over the past 20 years, high-penetrance pathogenic mutations in genes BRCA1, BRCA2, TP53, PTEN, STK1...
Purpose: The aim of this study is to further understand the status of BRCA1 and BRCA2 mutation among...
Importance: Rare germline genetic variants in several genes are associated with increased breast can...
Although evidence suggests an importance of genetic factors in the development of breast cancer in T...
Abstract Germline-somatic mutation interactions are universal and associated with tumorigenesis, but...
Introduction: Germline mutations of BRCA1 and BRCA2 account for the majority of hereditary breast ca...
Over the past 20 years, high-penetrance pathogenic mutations in genes BRCA1, BRCA2, TP53, PTEN, STK1...